Medable, Withings partner to use connected devices in decentralized clinical trials
21 Jul 2022
Collaborate
Preview
Source: mobihealthnews
Photo: Withings
Medable is partnering with Withings Health Solutions to use the company's connected devices for decentralized clinical trials.
"As the industry leader in plug-and-play connected sensor devices, Withings is the ideal partner for Medable as we continue driving for population representation in clinical trials," Dr. Michelle Longmire, cofounder and CEO of Medable, said in a statement. "Their devices are a critical part of a successful decentralized clinical trial – the third leg of the DCT stool – and we look forward to a long, successful partnership with Withings."
THE LARGER TREND
Decentralized clinical trials gained traction during the COVID-19 pandemic. Some experts argue adding virtual or remote components could improve diversity in clinical trials and curb dropout rates among participants.
A recent survey of cancer patients and survivors published in JMIR found decentralized clinical trial tech could increase interest in participating in trials, and most respondents were willing to use interventions like wearables, medications delivered to the home and electronic informed consent.
Medable is one larger player in the space. The company announced it had raised $304 million in Series D funding in October. This year, it announced a partnership with CVS to grow clinical trial engagement and acquired LEO Innovation Lab's dermatology-focused platform Omhu A/S.
But there are a number of other companies offering decentralized clinical trial technology, including uMotif, Curebase, THREAD and Reify Health.
Meanwhile, Withings Health Solutions, the healthcare industry-focused arm of the larger connected health tech company, recently rolled out a new remote patient monitoring program utilizing its devices.
Withings has had a busy year so far. It announced an upcoming smart scale in January, acquired French device-maker Impeto Medical and bought Berlin-based fitness and meal planning app 8fit.
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Targets
-Drugs
-Chat with Hiro
Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.